Role of Positron Emission Tomography/Computed Tomography in Breast Cancer
Authors:
- 1 September 2013
- journal article
- review article
- Published by Elsevier in Radiologic Clinics of North America
- Vol. 51 (5) , 781-798
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapyBreast Cancer Research and Treatment, 2012
- Can FDG PET/CT monitor the response to hormonal therapy in breast cancer patients?European Journal of Nuclear Medicine and Molecular Imaging, 2011
- FDG-avid sclerotic bone metastases in breast cancer patients: a PET/CT case seriesAnnals of Nuclear Medicine, 2011
- 18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniquesBreast Cancer Research and Treatment, 2011
- Initial clinical test of a breast-PET scannerJournal of Medical Imaging and Radiation Oncology, 2011
- Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imagingEuropean Journal of Nuclear Medicine and Molecular Imaging, 2010
- The role of FDG PET/CT in patients with locoregional breast cancer recurrence: A comparison to conventional imaging techniquesEuropean Journal of Surgical Oncology, 2010
- PET characteristics of a dedicated breast PET/CT scanner prototypePhysics in Medicine & Biology, 2009
- Significance of breast lesion descriptors in the ACR BI‐RADS MRI lexiconCancer, 2009